Insulin-like growth factor I as an angiogenic agent. In vivo and in vitro studies.
Grant
M B
MB
Department of Medicine, University of Florida College of Medicine, Gainesville 32610.
Mames
R N
RN
Fitzgerald
C
C
Ellis
E A
EA
Caballero
S
S
Chegini
N
N
Guy
J
J
D000818:Animals; D002455:Cell Division / Q000187:drug effects; D002478:Cells, Cultured; D002633:Chemotaxis / Q000187:drug effects; D003315:Cornea / Q000187:drug effects* / Q000473:pathology; D003692:Delayed-Action Preparations; D004343:Drug Implants; D004730:Endothelium, Vascular / Q000187:drug effects / Q000502:physiology*; D016222:Fibroblast Growth Factor 2 / Q000494:pharmacology; D006801:Humans; D066298:In Vitro Techniques; D007334:Insulin-Like Growth Factor I / Q000494:pharmacology*; D009389:Neovascularization, Pathologic; D011817:Rabbits; D011994:Recombinant Proteins / Q000494:pharmacology; D012171:Retinal Vessels / Q000166:cytology / Q000187:drug effects* / Q000473:pathology
D003692:Delayed-Action Preparations; D004343:Drug Implants; D011994:Recombinant Proteins; D016222:Fibroblast Growth Factor 2; D007334:Insulin-Like Growth Factor I